AstraZeneca’s Q4 revenue jumps 24% to $14.9B

AstraZeneca Plc. announced on Thursday that its revenue in the fourth quarter of its fiscal 2024 rose by 24% on an annual basis to $14.9 billion, exceeding analysts’ expectations. For the full 2024, t…